# Bluerock Homes Trust, Inc.: overview

BHM · NYSE · CIK 1903382 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bhm.md) · [Financials](/companies/bhm/financials.md) · [Filings](/companies/bhm/filings.md) · [Insiders](/companies/bhm/insiders.md)

Latest reported revenue: [$19.3m](/filings/0001104659-26-095875.md) for period not labelled, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:Revenues, accession 0001104659-26-095875).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-09-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | period not labelled (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [12.7](/filings/0001104659-25-107723.md) | [13.8 d](/filings/0001104659-26-021568.md) | [16.4](/filings/0001104659-26-057077.md) | [16.8](/filings/0001104659-26-095875.md) | [16.6](/filings/0001104659-25-107723.md) | [18.9 d](/filings/0001104659-26-021568.md) | [19.7](/filings/0001104659-26-057077.md) | [19.3](/filings/0001104659-26-095875.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [27.9%](/filings/0001104659-25-107723.md) | [(52.8%) d](/filings/0001104659-26-021568.md) | [(44.7%)](/filings/0001104659-26-057077.md) | [(34.7%)](/filings/0001104659-26-095875.md) | [(60.0%)](/filings/0001104659-25-107723.md) | [(50.1%) d](/filings/0001104659-26-021568.md) | [(52.3%)](/filings/0001104659-26-057077.md) | [(46.4%)](/filings/0001104659-26-095875.md) |
| Diluted EPS | $ per share | [0.24](/filings/0001104659-25-107723.md) | not reported | [(0.67)](/filings/0001104659-26-057077.md) | [(0.66)](/filings/0001104659-26-095875.md) | [(0.94)](/filings/0001104659-25-107723.md) | not reported | [(0.90)](/filings/0001104659-26-057077.md) | [(0.90)](/filings/0001104659-26-095875.md) |
| Free cash flow | $m | [(0.6) d](/filings/0001104659-25-107723.md) | [1.6 d](/filings/0001104659-26-021568.md) | [(2.9)](/filings/0001104659-26-057077.md) | [9.0 d](/filings/0001104659-26-095875.md) | [8.5 d](/filings/0001104659-25-107723.md) | [(4.2) d](/filings/0001104659-26-021568.md) | [(12.3)](/filings/0001104659-26-057077.md) | [(2.5) d](/filings/0001104659-26-095875.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY (2024-12-31) | FY (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [14.6](/filings/0001410578-23-000330.md) | [34.1](/filings/0001410578-24-000183.md) | [41.1](/filings/0001410578-25-000400.md) | [50.2](/filings/0001104659-26-021568.md) | [68.7](/filings/0001104659-26-021568.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [2.7%](/filings/0001410578-23-000330.md) | [(29.1%)](/filings/0001410578-23-000330.md) | not reported | not reported | not reported |
| Net margin | % | [234.6%](/filings/0001410578-23-000330.md) | [(2.9%)](/filings/0001410578-23-000330.md) | [(38.4%)](/filings/0001410578-25-000400.md) | [(24.1%)](/filings/0001104659-26-021568.md) | [(47.4%)](/filings/0001104659-26-021568.md) |
| Diluted EPS | $ per share | [8.93](/filings/0001410578-23-000330.md) | [(0.26)](/filings/0001410578-24-000183.md) | [(1.30)](/filings/0001410578-25-000400.md) | [(1.10)](/filings/0001104659-26-021568.md) | [(3.02)](/filings/0001104659-26-021568.md) |
| Free cash flow | $m | [8.1](/filings/0001410578-23-000330.md) | [(15.2)](/filings/0001410578-24-000183.md) | [4.4](/filings/0001410578-25-000400.md) | [(0.3)](/filings/0001104659-26-021568.md) | [10.4](/filings/0001104659-26-021568.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:ProfitLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bhm/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Quinn Opportunity Partners LLC](/funds/1633275.md) | 2026-06-30 | $2.1m | 228,282 |  | Unchanged |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.3m | 148,398 |  | Added +1,624 |
| [Arkadios Wealth Advisors](/funds/1800798.md) | 2026-06-30 | $1.1m | 121,770 |  | Added +12,119 |
| [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $768.6k | 85,395 |  | Reduced −2,709 |
| [TUDOR INVESTMENT CORP ET AL](/funds/923093.md) | 2026-06-30 | $600.8k | 66,761 |  | Unchanged |
| [RBF Capital, LLC](/funds/1134621.md) | 2026-06-30 | $521.6k | 57,954 |  | Unchanged |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $484.0k | 53,780 |  | Added +990 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $359.4k | 39,926 |  | Reduced −866 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $349.9k | 38,862 |  | Reduced −1,560 |
| [Bluespring Wealth Management, LLC](/funds/1557485.md) | 2026-06-30 | $316.3k | 35,143 |  | New +35,143 |

## Recent filings

[All 317 filings](/companies/bhm/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 17:25 ET | [8-K](/filings/0001104659-26-118199.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-118199 |
| 2026-10-20 | 16:06 ET | [8-K](/filings/0001104659-26-117412.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-26-117412 |
| 2026-10-06 | 13:29 ET | [8-K](/filings/0001104659-26-113975.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-26-113975 |
| 2026-09-02 | 16:08 ET | [8-K](/filings/0001104659-26-104731.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-26-104731 |
| 2026-08-14 | 13:55 ET | [8-K](/filings/0001104659-26-096869.md) | 3.02 Unregistered sale of equity | 0001104659-26-096869 |
| 2026-08-13 | 16:01 ET | [10-Q](/filings/0001104659-26-095875.md) | Quarterly report, period 2026-06-30 | 0001104659-26-095875 |
| 2026-08-12 | 12:41 ET | [8-K](/filings/0001104659-26-094678.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-26-094678 |
| 2026-08-11 | 12:45 ET | [8-K](/filings/0001104659-26-093930.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-26-093930 |
| 2026-08-10 | 16:21 ET | [8-K](/filings/0001104659-26-093404.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-093404 |
| 2026-06-11 | 13:03 ET | [8-K](/filings/0001104659-26-072788.md) | 5.07 Shareholder vote results | 0001104659-26-072788 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-021568.md), filed Feb 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1903382
- Tickers: BHM
- Exchange: NYSE
- SIC code: 6798 Real Estate Investment Trusts
- State of incorporation: MD
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:13 ET. No prices; not investment advice.